Clopidogrel Clinical Trial
Official title:
Evaluation of Clopidogrel Use in Peri-Operative General Surgery Patients: A Prospective Study
Patients who on taking clopidogrel are randomized to either continue clopidogrel into general surgery or discontinue clopidogrel 7 days before surgery. All patients resume clopidogrel after surgery. The investigators track the development of bleeding complications that may develop within 90 days of the surgery. Patients are medically cleared to be in either arm of the study by their cardiologist and surgeon. There is currently no evidence to support for or against the use continuation or discontinuation of clopidogrel prior to general surgery.
n/a
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03613337 -
Effect of Smoking Status and Genetic Risk Factors on Restenosis and Efficacy of Clopidogrel After de Novo Percutaneous Coronary Intervention
|
||
Completed |
NCT01582217 -
Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition
|
N/A | |
Completed |
NCT02484924 -
The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome
|
||
Completed |
NCT04431349 -
Comparison of CABG Related Bleeding Complications in Patients Treated With Ticagrelor or Clopidogrel
|
||
Completed |
NCT00753753 -
VerifyNow French Registry
|
N/A | |
Completed |
NCT05512546 -
The Prevention of Thromboembolic Complications Associated With Coil Embolization
|
||
Completed |
NCT01231867 -
Cohort Study of Clopidogrel and Proton Pump Inhibitors
|
N/A | |
Withdrawn |
NCT00363753 -
Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack
|
Phase 1 | |
Completed |
NCT00619073 -
PACT (Platelet Activity After Clopidogrel Termination)
|
N/A |